FR941202-0-00025 FR941202-0-00001 (ii) This individual meets the requirements specified in 10 CFR 35.980(b) and 35.972 and the licensee has received an approved license amendment identifying this individual as an authorized nuclear pharmacist, or (iii) This individual is designated as an authorized nuclear pharmacist in accordance with paragraph (b)(3) of this section. (3) The actions authorized in paragraphs (b)(1) and (b)(2) of this section are permitted in spite of more restrictive language in license conditions. (4) May designate a pharmacist (as defined in 10 CFR 35.2) as an authorized nuclear pharmacist if the individual is identified as of (the date of publication in the Federal Register ) as an ``authorized user'' on a nuclear pharmacy license issued by the Commission under this part. (5) Shall provide to the Commission a copy of each individual's certification by the Board of Pharmaceutical Specialties, the Commission or Agreement State license, or the permit issued by a licensee of broad scope, and a copy of the state pharmacy licensure or registration, no later than 30 days after the date that the licensee allows, pursuant to paragraphs (b)(2)(i) and (b)(2)(iii) of this section, the individual to work as an authorized nuclear pharmacist. (c) A licensee shall possess and use instrumentation to measure the radioactivity of radioactive drugs. The licensee shall have procedures for use of the instrumentation. The licensee shall measure, by direct measurement or by combination of measurements and calculations, the amount of radioactivity in dosages of alpha-, beta-, or photon-emitting radioactive drugs prior to transfer for commercial distribution. In addition, the licensee shall: (1) Perform tests before initial use, periodically, and following repair, on each instrument for accuracy, linearity, and geometry dependence, as appropriate for the use of the instrument; and make adjustments when necessary; and (2) Check each instrument for constancy and proper operation at the beginning of each day of use. (d) Nothing in this section relieves the licensee from complying with applicable FDA, other Federal, and State requirements governing radioactive drugs. §32.73 [Removed] 8. Section 32.73 is removed. 9. In §32.303, paragraph (b) is revised to read as follows: §32.303 Criminal penalties. * * * * * (b) The regulations in Part 32 that are not issued under subsections 161b, 161i, or 161o for the purposes of section 223 are as follows: §§32.1, 32.2, 32.8, 32.11, 32.14, 32.17, 32.18, 32.22, 32.23, 32.24, 32.26, 32.27, 32.28, 32.51, 32.53, 32.57, 32.61, 32.71, 32.74, 32.301, and 32.303.
